Key result
This review summarizes recent evidence on the analgesic efficacy, maternal side effects, and fetal well-being associated with neuraxial opioids for labor analgesia.
Why the study?
What is the analgesic efficacy, maternal side effect profile, and effect on foetal well-being of neuraxial opioids for labour analgesia?
What is the analgesic efficacy, maternal side effect profile, and effect on foetal well-being of neuraxial opioids for labour analgesia?
This review highlights the efficacy and potential side effects, particularly foetal bradycardia, of neuraxial opioids used for labour analgesia.
Alerts to fetal bradycardia risks with neuraxial opioids; leaves open optimal dosing strategies for future trials.
Neuraxial opioids have changed the practice of obstetric anaesthesia and analgesia dramatically. Excellent analgesia with minimal side effects started an era of ever increasing numbers of women who opt for the 'painless birth experience'. Several papers have been reported during 2001 that examine analgesic efficacy, maternal side effects, and effect on foetal well-being of epidural and spinal opioids. Foetal bradycardia following intrathecal opioid analgesia, an increasingly popular technique, has attracted particular attention over the past few years. The present review addresses recently reported work that, according to the author, is key to this field.
No takes yet. Share an insight, caveat, or question.
Marc Van de Velde (2002) conducted a review in Labour. Neuraxial opioids (epidural and spinal) was evaluated on Analgesic efficacy, maternal side effects, and effect on foetal well-being. This review summarizes recent evidence on the analgesic efficacy, maternal side effects, and fetal well-being associated with neuraxial opioids for labor analgesia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: